The second group, “MYC-complex” included lymphomas with IG-MYC fusions or non–IG-MYC fusions that have a high chromosomal complexity score (≥6), an IGH-BCL2 fusion, BCL6 breakpoint, or any combination of these. The gene discussed is MYC; the disease is lymphoma.